• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) QUADRA ASSURA CRT-D QUAD RF HV; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) QUADRA ASSURA CRT-D QUAD RF HV; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD3365-40Q
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Complete Heart Block (2627)
Event Type  Injury  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Related manufacturer reference number: 2017865-2020-17011, 2017865-2020-17012, 2017865-2020-17013.It was reported that the patient presented in clinic for a prophylactic replacement of possibly an infected left-sided cardiac resynchronization therapy defibrillator (crt-d) system.The patient reportedly had a transfer from another institution where he was observed for sepsis, possibly emanating from the leads in the crt-d system or from a since replaced peripherally inserted central catheter (picc) line.It was concluded that full system extraction was necessary as the sepsis had not abated while the patient was undergoing antibiotic therapy.Pre-procedure system measurements revealed no abnormalities.During the extraction process, the patient experienced complete heart block, and when venous access couldn¿t be obtained, a femoral access and temporary pacing line was deployed to support the patient for the remainder of the procedure.Full extraction was successful, and a new, right-sided crt-d was implanted with optimal test results obtained.The patient was stable.
 
Manufacturer Narrative
Additional information: h6.
 
Manufacturer Narrative
Interrogation of the device revealed it was above eri when received.Based on this information, the device was found to communicate appropriately with a merlin programmer and has not reached the elective replacement indicator (eri).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUADRA ASSURA CRT-D QUAD RF HV
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key10775987
MDR Text Key214297450
Report Number2017865-2020-17010
Device Sequence Number1
Product Code NIK
UDI-Device Identifier05414734508292
UDI-Public05414734508292
Combination Product (y/n)N
PMA/PMN Number
P030054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 05/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2017
Device Model NumberCD3365-40Q
Device Catalogue NumberCD3365-40Q
Device Lot NumberA000008036
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/26/2021
Was the Report Sent to FDA? No
Date Manufacturer Received04/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR; OPTISENSE LEAD; QUARTET; DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR; OPTISENSE LEAD; QUARTET
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient Weight77
-
-